Modulation of Reoviral Cytolysis (I): Combination Therapeutics

Patients with stage IV gastric cancer suffer from dismal outcomes, a challenge especially in many Asian populations and for which new therapeutic options are needed. To explore this issue, we used oncolytic reovirus in combination with currently used chemotherapeutic drugs (irinotecan, paclitaxel, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Yoshinori, Nishikawa, Sandra G., Fratiloiu, Andreea R., Tsutsui, Mio, Kataoka, Hiromi, Joh, Takashi, Johnston, Randal N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385176/
https://www.ncbi.nlm.nih.gov/pubmed/37515160
http://dx.doi.org/10.3390/v15071472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385176/
https://www.ncbi.nlm.nih.gov/pubmed/37515160
http://dx.doi.org/10.3390/v15071472

Ejemplares similares